Literature DB >> 9285089

Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.

J Friedman1, K Ault, P Powchik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9285089     DOI： 10.1016/S0006-3223(97)00227-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  9 in total

1.  Pimozide augmentation in a patient with drug-resistant psychosis previously treated with olanzapine.

Authors:  J Takhar
Journal:  J Psychiatry Neurosci       Date:  1999-05       Impact factor: 6.186

Review 2.  Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

Authors:  Constantin Tranulis; Leila Skalli; Pierre Lalonde; Luc Nicole; Emmanuel Stip
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy.

Authors:  Joseph I Friedman; Jean-Pierre Lindenmayer; Frances Alcantara; Stephanie Bowler; Mohan Parak; Leonard White; Adel Iskander; Michael Parrella; David N Adler; Nicholas D Tsopelas; Wei-Yann Tsai; Vladan Novakovic; Vladan Novakovick; Philip D Harvey; Kenneth L Davis; Saurabh Kaushik
Journal:  Neuropsychopharmacology       Date:  2011-02-23       Impact factor: 7.853

5.  Clozapine: Current perspective.

Authors:  Ram K Solanki; Paramjeet Singh; Mukesh K Swami
Journal:  Indian J Psychiatry       Date:  2007-10       Impact factor: 1.759

6.  Concept and Management of Treatment Resistant Schizophrenia (TRS).

Authors:  Nitesh Painuly; Nitin Gupta; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2004-04       Impact factor: 1.759

7.  Treatment of the special patient with schizophrenia.

Authors:  R R Conley; D L Kelly
Journal:  Dialogues Clin Neurosci       Date:  2001-06       Impact factor: 5.986

8.  Treatment-refractory schizophrenia.

Authors:  Asaf Caspi; Michael Davidson; Carol A Tamminga
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

9.  Current perspectives in the treatment of resistant schizophrenia.

Authors:  R K Solanki; Paramjeet Singh; Deepti Munshi
Journal:  Indian J Psychiatry       Date:  2009 Oct-Dec       Impact factor: 1.759
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.